Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bacterial toxins and gut irritants represent a diverse group of substances produced by pathogenic bacteria or encountered in the gastrointestinal lumen that disrupt normal intestinal homeostasis. These include exotoxins, such as those from Vibrio cholerae or Clostridioides difficile, and endotoxins like lipopolysaccharides, which trigger excessive fluid secretion and inflammation by activating intracellular signaling pathways like the cystic fibrosis transmembrane conductance regulator (CFTR) (PubMed: 9446464). Gut irritants also encompass endogenous factors like malabsorbed bile acids or exogenous dietary components that provoke similar secretory or inflammatory responses (StatPearls: NBK549910). In therapeutic contexts, these entities are targeted to manage conditions like infectious diarrhea, traveler's diarrhea, and irritable bowel syndrome. Treatment strategies involve luminal binders like cholestyramine that adsorb toxins, neutralizing monoclonal antibodies like bezlotoxumab, or agents like crofelemer that block the physiological consequences of toxin-induced signaling (NEJM: 28148186, PubMed: 23195660). Consequently, while this category is broad and represents a functional group rather than a single molecular entity, it remains a primary focus for developing anti-diarrheal and anti-infective therapies.
Toxin neutralization via monoclonal antibodies, luminal adsorption and physical binding, and inhibition of downstream secretory signaling pathways such as the CFTR chloride channel.
8 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial toxins and gut irritants.